18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/17/2019 |
Start Date: | August 2, 2017 |
End Date: | April 2021 |
Contact: | Andrea Otte, DPT |
Email: | anotte@stanford.edu |
Phone: | (650) 736-4183 |
The investigators will evaluate the detection of cardiac sarcoidosis or inflammation using
18F-FSPG PET/MRI.
18F-FSPG PET/MRI.
PET/MRI scans will be performed with a whole-body PET/MR imaging system capable of
simultaneous PET and MR imaging (SIGNA, GE Healthcare, Milwaukee, WI). Approximately 45-60
minutes after IV injection of 8 mCi of 18F-FSPG, PET emission scanning and MRI acquisition T1
weighted scanning will begin imaging both whole body and the heart.
simultaneous PET and MR imaging (SIGNA, GE Healthcare, Milwaukee, WI). Approximately 45-60
minutes after IV injection of 8 mCi of 18F-FSPG, PET emission scanning and MRI acquisition T1
weighted scanning will begin imaging both whole body and the heart.
Inclusion Criteria:
- Patient is ≥ 18 years old at the time of the scan
- Patient with known or suspected cardiac sarcoidosis.
- Patient is capable of complying with study procedures
- Patient can remain still for duration of imaging procedure
Exclusion Criteria:
- Patient is pregnant or nursing
- Metallic implants (contraindicated for MRI)
- History of renal insufficiency (only for MRI contrast administration)
We found this trial at
1
site
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
Click here to add this to my saved trials